Drug Trial Radar · NCT05784688
Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors
Last checked: Nov 19, 2026Latest source record: Mar 30, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
140
Planned (sponsor's estimate)
Start
Mar 10, 2023
Primary completion
Dec 2026
Study completion Dec 2028
Sponsor
- Lead sponsor
- TiumBio Co., Ltd.Industry
- Sponsor type
- Industry
- Collaborators
- Merck Sharp & Dohme LLC
- First posted
- Mar 27, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study consists of phase 1b and 2a to evaluate safety, Pharmacokinetics, and efficacy of TU2218 in combination with Pembrolizumab in patients with advanced solid tumors.
Conditions
- Solid Tumor
- Biliary Tract Cancer
- Head and Neck Squamous Cell Carcinoma
- Colorectal Cancer
Interventions
TU2218 + KEYTRUDA® (Pembrolizumab)Drug
TU2218: Orally administered KEYTRUDA® (Pembrolizumab): Intravenously administered
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phase 1b: To determine the Recommended Phase 2 Dose of the Combination (RP2DC) of TU2218 given with Pembrolizumab in selected advanced solid tumorsTime frame: During the first 21-day period (Cycle 1)
- Phase 2a: To evaluate the efficacy of TU2218 by evaluating the Overall Response rate (ORR) of TU2218 administered in combination with Pembrolizumab in selected advanced solid tumorsTime frame: 24 weeks
Locations
11 sites in 2 countries. Site status is shown where the registry gives one.
NEXT Oncology
San Antonio, Texas · Active not recruiting
Hope Cancer Center
Tyler, Texas · Active not recruiting
Medical Oncology
Spokane, Washington · Active not recruiting
CHA University Bundang Medical Center
Seongnam, South Korea · Recruiting
Seoul National University Bundang Hospital
Seongnam, South Korea · Recruiting
Asan Medical Center
Seoul, South Korea · Recruiting
Samsung Medical Center
Seoul, South Korea · Recruiting
Seoul National University Hospital
Seoul, South Korea · Recruiting
Severance Hospital
Seoul, South Korea · Recruiting
The Catholic University of Korea Seoul St. Mary Hospital
Seoul, South Korea · Recruiting
The Catholic University of Korea St. Vincent's Hospital
Suwon, South Korea · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.